Franklin Resources, Inc. 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 11:08 am Sale | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | FRANKLIN RESOURCES INC BEN | 0 0.000% | -4,713,014 (Position Closed) | Filing |
| 2024-10-31 1:05 pm Purchase | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | FRANKLIN RESOURCES INC BEN | 4,713,014 8.600% | 879,059 (+22.93%) | Filing |
| 2024-02-06 11:58 am Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | FRANKLIN RESOURCES INC BEN | 3,833,955 7.000% | 3,833,955 (New Position) | Filing |